Brad Goskowicz

CEO
Microbiologics Inc.

Microbiologics has a very distinctive product—microbial biomaterials such as bacteria, viruses and microscopic parasites that are freeze-dried but still viable. Customers worldwide, including food-production laboratories and hospitals, use these bugs to test their quality control systems. Microbiologics’ $7.25 million expansion will add 30,000 square feet of lab, production and office space. The project is expected to add 35 new jobs on top of 120 already in place. (In 2009, when Goskowicz became CEO, Microbiologics had 55.) The company’s continued growth reflects the St. Cloud region’s economic strength.